4.8 Article

ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis

期刊

CELL REPORTS
卷 37, 期 3, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2021.109858

关键词

-

资金

  1. National Institutes of Health [AI101935, AI124346, AI160179, AR056296, CA253095]
  2. American Lebanese Syrian Associated Charities

向作者/读者索取更多资源

The study uncovers the role of ADAR1 in suppressing ZBP1-mediated PANoptosis and promoting tumorigenesis. Additionally, the use of IFN-gamma and NEI KPT-330 regresses melanoma in a ZBP1-dependent manner, providing important insights for cancer therapeutic strategies.
Cell death provides host defense and maintains homeostasis. Za-containing molecules are essential for these processes. Z-DNA binding protein 1 (ZBP1) activates inflammatory cell death, PANoptosis, whereas adenosine deaminase acting on RNA 1 (ADAR1) serves as an RNA editor to maintain homeostasis. Here, we identify and characterize ADAR1's interaction with ZBP1, defining its role in cell death regulation and tumorigenesis. Combining interferons (IFNs) and nuclear export inhibitors (NEIs) activates ZBP1-dependent PANoptosis. ADAR1 suppresses this PANoptosis by interacting with the Z alpha 2 domain of ZBP1 to limit ZBP1 and RIPK3 interactions. Adar1(fl/fl)LysM(cre) mice are resistant to development of colorectal cancer andmelanoma, but deletion of the ZBP1 Za2 domain restores tumorigenesis in these mice. In addition, treating wild-type mice with IFN-gamma and the NEI KPT-330 regresses melanoma in a ZBP1-dependent manner. Our findings suggest that ADAR1 suppresses ZBP1-mediated PANoptosis, promoting tumorigenesis. Defining the functions of ADAR1 and ZBP1 in cell death is fundamental to informing therapeutic strategies for cancer and other diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据